Generics News

Generics News

Perrigo Launches Generic Kenalog Spray

Perrigo announced the launch of Triamcinolone Acetonide Topical Aerosol, the generic version of Sun Pharma's Kenalog spray.

First Generic Version of Copaxone Now Approved

The Food and Drug Administration (FDA) has approved Sandoz's Glatiramer Acetate Injection, the first generic version of Teva's Copaxone.

Generic Exalgo Coming Soon from Perrigo

Perrigo announced that it has received final approval from the Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Hydromorphone HCI Extended-Release Tablets, the generic version of Mallinckrodt's Exalgo.

First Generic Version of Generess Fe Launched

Mylan announced the launch of Norethindrone and Ethinyl Estradiol Tablets 0.8mg/0.025mg and Ferrous Fumarate Tablets 75mg, the generic version of Warner Chilcott's Generess Fe.

ANI Launches Generic Rythmol Tablets

ANI Pharmaceuticals announced the availability of Propafenone HCl Tablets, the generic version of GlaxoSmithKline's Rythmol.

Teva Launches Generic Exforge

Teva announced the launch of Amlodipine and Valsartan Tablets, the generic version of Novartis' Exforge.

New Fentanyl Dosage Strengths Launched By Mylan

Mylan announced the launch of Fentanyl Transdermal System 37.5mcg/hr, 62.5mcg/hr, and 87.5mcg/hr, three new intermediate dosage strengths.

Mylan Launches Generic Antabuse

Mylan announced the launch of Disulfiram Tablets, the generic version of Odyssey's Antabuse.

Mylan Launches Generic Subutex

Mylan announced the launch of Buprenorphine HCl Sublingual Tablets, the generic version of Reckitt Benckiser's Subutex.

Etodolac Capsules Launched by ANI

ANI Pharmaceuticals announced the launch of Etodolac 200mg Capsules, formerly known under the brand name Lodine.